Call for pharmacist access to the MBS for Chronic Disease Management

0
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Treating hypertension – a new approach

0
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Resistance movement: Pharmacy’s fight against antimicrobial resistance

0
Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...

Re-thinking opioids

0
Pharmacists can minimise opioid harm by helping patients step down. While opioids play an important role in the management of acute pain, their widespread use...

PSA’s projects make a bigger impact than ever before

0
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Choosing wisely to achieve medicine safety

0
The quality use of medicines is vital to ensure a sustainable healthcare system and better health outcomes for consumers. This was the dominant theme at...